Mauna Kea Technologies SAS

Headquartered in Paris, France, Mauna Kea Technologies S.A. commenced operations in 2000. This company specializes in developing and commercializing medical devices, with a broad market presence spanning Europe, the Middle East, Africa, the Americas, and Asia. A primary focus for Mauna Kea Technologies is creating and distributing instruments designed to enable the real-time detection and visualization of cellular irregularities. These innovative tools are utilized during standard endoscopic examinations of the gastrointestinal and pulmonary systems. Their leading product, Cellvizio, stands as a prime example: it is an advanced confocal miniprobe endomicroscopy system. Cellvizio delivers exceptionally detailed, cellular-level images of tissues to both physicians and scientific researchers.